FibroBiologics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
FBLG Company Description
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
FBLG Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view FBLG Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of FBLG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FBLG's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of FBLG in WallStreetBets Daily Discussion
FBLG News
Recent insights relating to FBLG
CNBC Recommendations
Recent picks made for FBLG stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in FBLG
Corporate Flights
Flights by private jets registered to FBLG
Our Analysis